oxidopamine has been researched along with Ptosis, Eyelid in 2 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flach, AJ | 1 |
| Peterson, JS | 1 |
| Roizen, MF | 1 |
| Wood, IS | 1 |
| Purpura, P | 1 |
| Westman, L | 1 |
| Will, P | 1 |
| Eidelman, A | 1 |
| Kagan, VE | 1 |
| Osipov, AN | 1 |
| Schor, NF | 1 |
2 other studies available for oxidopamine and Ptosis, Eyelid
| Article | Year |
|---|---|
Ptosis in the rat following topically administered 2% epinephrine.
Topics: Administration, Topical; Animals; Blepharoptosis; Catecholamines; Epinephrine; Eyelids; Hydroxydopam | 1983 |
Adjunctive treatment of murine neuroblastoma with 6-hydroxydopamine and Tempol.
Topics: Adrenergic Agents; Animals; Antioxidants; Blepharoptosis; Catalase; Cyclic N-Oxides; Dopamine; Drug | 1996 |